Home Infusion Therapy Market Report by Product, Application, Countries and Company Analysis 2026-2034

Home Infusion Therapy Market Size and Forecast

Home Infusion Therapy Market is projected to grow from US$ 45.28 billion in 2025 to US$ 74.07 billion by 2034, registering a CAGR of 5.62% during 2026–2034. The market is expected to experience steady expansion as healthcare systems increasingly emphasize cost-effective treatment delivery and patient-centered care. The rising prevalence of chronic diseases requiring long-term medication and therapeutic support is also increasing demand for home-based infusion services. In addition, growing patient preference for receiving appropriate treatments in the comfort of their homes, rather than making frequent hospital or clinic visits, is supporting market development.

What is Home Infusion Therapy and its Uses & Popularity Worldwide

Home infusion therapy is a healthcare service that enables patients to receive medications, fluids, nutrients, or other therapies intravenously or through other infusion routes in their homes rather than visiting hospitals or outpatient facilities. It commonly includes anti-infective therapy, chemotherapy, hydration therapy, enteral and parenteral nutrition, immunoglobulin therapy, pain management, and other long-term treatments.

Home infusion programs generally combine infusion pumps and supplies with medications, nursing support, clinical monitoring, and patient education. The model is increasingly important as healthcare systems seek convenient, patient-centered treatment options while reducing pressure on hospitals. A systematic review also found home infusion costs were US$1,928–US$2,974 lower per treatment course than medical-setting infusion in the studies reviewed. Growing acceptance among patients, caregivers, healthcare providers, and insurers is therefore supporting wider adoption worldwide.

Market Growth Drivers

Rising Prevalence of Chronic Diseases

The growing global burden of chronic diseases is a major factor supporting demand for home infusion therapy because many patients require prolonged or repeated medication and nutritional support. According to the World Health Organization (WHO), noncommunicable diseases caused at least 43 million deaths in 2021, representing approximately 75% of non-pandemic-related deaths worldwide. Cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes accounted for the largest share of these deaths. Several patients with chronic or complex conditions require therapies that may be delivered safely outside conventional hospital environments, including intravenous antibiotics, immunoglobulins, hydration, nutrition, and certain oncology treatments. Home infusion can reduce the need for repeated hospital visits while allowing treatment to continue within a familiar environment. A systematic review of home infusion found that patients generally preferred home-based treatment and reported improvements in well-being and reduced disruption to family and personal responsibilities. As chronic disease prevalence and long-term treatment requirements increase globally, healthcare providers are increasingly exploring home-based delivery models to complement conventional hospital care.

Growing Aging Population and Demand for Home-Based Care

Global population aging is increasing the need for accessible healthcare services that can support people with multiple chronic conditions and long-term treatment requirements. WHO reports that the global population aged 60 years and older is projected to increase from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050. The number of people aged 80 years and older is also expected to reach approximately 426 million by 2050. Older adults are more likely to require ongoing medical management, rehabilitation, nutritional support, and repeated medication administration, creating opportunities for home-based treatment models. Home infusion can provide selected therapies without requiring patients to travel frequently to hospitals or infusion centers. It can also help caregivers participate in treatment under professional supervision. The increasing emphasis on aging in place and patient-centered care is encouraging healthcare systems to develop services that shift appropriate treatment from institutional settings toward patients’ homes. As populations age across North America, Europe, and increasingly Asia-Pacific, the need for convenient, clinically supervised home healthcare is expected to strengthen demand for home infusion therapy.

Cost Efficiency and Healthcare System Capacity

The potential to reduce healthcare utilization and improve hospital capacity is another important growth driver for home infusion therapy. Hospitals worldwide face pressure from rising treatment costs, workforce shortages, increasing patient volumes, and demand for inpatient beds. Home-based infusion can allow appropriate patients to receive selected therapies without occupying hospital or outpatient infusion capacity. Evidence from a systematic review found that home infusion treatment generated US$1,928–US$2,974 in savings per treatment course compared with treatment in medical settings, while patients generally reported strong preferences for home treatment. More recent hospital-at-home evidence from England involving nearly 3,000 care episodes reported an average reduction of 3.13 hospital bed-days compared with matched inpatient controls and net savings of £3.79 million over 33 months. Although hospital-at-home and home infusion are not identical models, the findings illustrate the broader economic potential of appropriately designed home-based care. As healthcare organizations increasingly focus on value-based care, reducing unnecessary facility utilization while maintaining treatment quality can support further adoption of home infusion services.

Challenges in the Market

Clinical Safety, Monitoring, and Patient Selection

Clinical safety and the complexity of administering infusion therapies at home remain important challenges for market expansion. Unlike conventional hospital settings, home infusion requires appropriate patient selection, trained healthcare professionals, reliable equipment, medication management, infection-control procedures, and mechanisms for responding to adverse events. Some therapies may involve complex dosing or monitoring requirements and may therefore be unsuitable for certain patients or home environments. A systematic review of home infusion identified 13 studies meeting its inclusion criteria from 253 potentially relevant articles, highlighting variability in disease states, study designs, and outcomes. The review nevertheless found that home infusion patients were no more likely to experience adverse drug events or side effects than patients receiving treatment in medical settings. Even with favorable evidence, providers must maintain strict protocols for vascular access, infusion pumps, medication storage, emergency response, and follow-up. Variations in home infrastructure, caregiver availability, health literacy, and nursing support can further complicate implementation, particularly in rural or underserved regions.

Reimbursement, Workforce, and Infrastructure Constraints

Limited reimbursement coverage, shortages of skilled healthcare professionals, and uneven home healthcare infrastructure can restrict the adoption of home infusion therapy across markets. Home infusion requires coordination among physicians, pharmacists, nurses, suppliers, insurers, patients, and caregivers, creating a comparatively complex delivery ecosystem. Differences in reimbursement policies can also influence whether home infusion represents an economically attractive option for providers and patients. In addition, successful treatment may depend on trained infusion nurses, pharmacists, remote monitoring capabilities, dependable electricity and connectivity, appropriate medication storage, and timely delivery of supplies. These requirements can be particularly challenging in rural areas and lower-resource healthcare systems. The challenge is significant because the global population requiring healthcare support is becoming older and more geographically dispersed. WHO projects that by 2050, approximately 80% of the world’s older population will live in low- and middle-income countries, increasing the need for scalable healthcare delivery models. Expanding reimbursement frameworks, workforce training, digital monitoring, and distribution networks will therefore be important for wider and more consistent adoption of home infusion therapy worldwide.

Growing Adoption of Portable and Smart Infusion Pumps

Home Infusion Pump Market is gaining importance as healthcare providers increasingly use automated devices to deliver medications and therapeutic fluids safely and accurately in home settings. These pumps are used for antibiotics, chemotherapy, pain management, hydration, parenteral nutrition, and other intravenous therapies. According to the World Health Organization, noncommunicable diseases accounted for approximately 74% of deaths globally in 2021, highlighting the substantial population requiring long-term disease management. The increasing chronic disease burden is therefore creating demand for technologies that support repeated treatment outside hospitals. Portable and intelligent infusion pumps are gaining popularity because they provide programmable dosage and flow-rate control while incorporating alarms and safety mechanisms. Advanced models can also support wireless connectivity and remote monitoring, allowing healthcare professionals to supervise treatment more effectively. The broader shift toward home healthcare is encouraging manufacturers to develop smaller, easier-to-use, and more connected devices. Growing patient preference for convenient treatment, combined with healthcare providers’ efforts to reduce hospital utilization, is expected to support continued demand for home infusion pumps worldwide.

Rising Demand for Sterile and Safety-Enhanced IV Components

Home Infusion Intravenous Sets Market includes tubing systems, connectors, catheters, needles, and related accessories used to administer medications and fluids safely through intravenous routes. These products are essential for delivering antibiotics, hydration solutions, parenteral nutrition, biologic therapies, and other treatments in home environments. The market is benefiting from the broader expansion of home infusion services and the increasing number of patients receiving long-term therapies outside hospitals. According to WHO, chronic diseases cause approximately 41 million deaths annually worldwide, representing around 74% of all non-pandemic-related deaths and creating sustained demand for long-term treatment solutions. Manufacturers are increasingly incorporating anti-kink tubing, needle-free connectors, secure connections, and infection-prevention features to improve patient safety. Sterility and single-use designs are particularly important because home environments generally have fewer clinical resources than hospitals. As healthcare systems continue shifting appropriate treatments toward home settings, demand for reliable IV administration products is expected to increase. Improvements in product ergonomics, packaging, connector technology, and ease of use will further support market development.

Expansion of Home-Based Fluid and Electrolyte Management

Home Infusion Hydration Therapy Market involves administering intravenous fluids and electrolytes to patients in their homes when oral hydration is insufficient or inappropriate. The therapy can be used for patients experiencing dehydration associated with chronic diseases, cancer treatment, gastrointestinal disorders, infections, postoperative recovery, and other medical conditions. The aging population is an important demand factor because older adults may experience greater difficulty maintaining adequate hydration and traveling frequently to healthcare facilities. WHO estimates that the global population aged 60 years and older will reach 1.4 billion by 2030, up from 1 billion in 2020. This demographic shift is increasing demand for healthcare models capable of supporting patients outside institutional settings. Home hydration programs can provide greater convenience while potentially reducing unnecessary emergency department and hospital visits for appropriately selected patients. Portable infusion pumps, remote monitoring technologies, and professional home nursing services are improving the feasibility of treatment. Growing awareness of preventive healthcare and patient-centered care is also encouraging providers to establish dedicated home hydration services. These trends are expected to create additional opportunities for home infusion hydration therapy.

Increasing Interest in Selected Oncology Treatments at Home

Home Infusion Chemotherapy Therapy Market is developing as healthcare providers seek appropriate ways to deliver selected cancer treatments outside conventional hospitals and infusion centers. Certain anticancer medications can be administered continuously through intravenous infusion using portable pumps and specialized clinical supervision. This approach may reduce hospital and infusion-center visits for eligible patients while providing greater comfort and flexibility during treatment. The global cancer burden provides an important underlying demand factor. According to the International Agency for Research on Cancer, approximately 20 million new cancer cases and 9.7 million cancer deaths were estimated worldwide in 2022. As cancer incidence increases, healthcare systems are exploring alternative treatment-delivery models to accommodate growing demand. Developments in portable infusion pumps, vascular-access devices, remote monitoring, and specialized oncology nursing are improving home-based treatment capabilities. However, chemotherapy requires rigorous safety procedures because of the potential toxicity and complexity of anticancer medicines. Appropriate patient selection, trained personnel, medication preparation, adverse-event monitoring, emergency protocols, and safe disposal procedures remain essential. Increasing oncology demand and investment in specialized home-care infrastructure are expected to support measured expansion of this market.

United States Established Healthcare Infrastructure Supports Market Expansion

United States Home Infusion Therapy Market is supported by a large chronic disease population, an aging demographic, advanced healthcare infrastructure, and established home healthcare networks. According to the U.S. Centers for Disease Control and Prevention, 6 in 10 adults in the United States have at least one chronic disease, while 4 in 10 have two or more chronic conditions. This substantial patient population creates continued demand for long-term treatment and medication-management services. Home infusion is used for therapies including intravenous antibiotics, nutrition, immunoglobulins, hydration, and selected specialty medications. The United States also has an extensive network of specialty pharmacies, home infusion providers, nurses, pharmacists, and medical-device suppliers. Advances in smart infusion pumps and remote monitoring are improving treatment management and patient convenience. Reimbursement from Medicare, Medicaid, and private insurers can further facilitate access, although coverage varies according to therapy and patient circumstances. In April 2024, CVS Health announced an expansion of its Coram home infusion capabilities, demonstrating continued investment in home-based infusion and specialty pharmacy services. Workforce shortages, reimbursement complexity, and supply-chain challenges remain important market constraints.

Germany Aging Demographics and Healthcare Capacity Drive Home Treatment

Germany’s Home Infusion Therapy Market is benefiting from population aging, chronic disease prevalence, and the country’s developed healthcare infrastructure. According to Eurostat, people aged 65 years and over represented approximately 22% of Germany’s population in 2024, placing the country among Europe’s older populations. Older patients are more likely to require long-term management of complex conditions and may benefit from appropriately supervised treatments delivered at home. Home infusion services can support patients requiring parenteral nutrition, antibiotics, hydration, and selected specialty therapies while reducing the need for repeated visits to medical facilities. Germany’s established healthcare and reimbursement infrastructure provides a foundation for the development of home-based treatment services. Portable infusion pumps, digital monitoring systems, and improved nursing support are further increasing the feasibility of home administration. In October 2023, Fresenius Kabi expanded its infusion-therapy services in Germany, including support for home-based parenteral nutrition and specialty infusion care. Nevertheless, regulatory requirements, shortages of specialized healthcare workers, and medication and equipment logistics can restrict expansion. Continued healthcare optimization and patient preference for home-based care are expected to support future market development.

India Expanding Chronic Disease Burden Creates New Opportunities

India’s Home Infusion Therapy Market is emerging as healthcare providers and patients increasingly seek convenient alternatives to prolonged hospital-based treatment. The country’s large and growing chronic disease burden provides a substantial underlying patient base. The International Diabetes Federation estimates that approximately 89.8 million adults aged 20–79 in India were living with diabetes in 2024, making India one of the world’s largest diabetes populations. Cancer, cardiovascular diseases, infections, and other chronic conditions can also require prolonged medication or supportive treatment. Home infusion can reduce the need for repeated hospital visits when therapies are clinically appropriate and administered under professional supervision. Growth in telemedicine, digital health platforms, private healthcare investment, and organized home healthcare services is improving the infrastructure needed for treatment at home. However, uneven healthcare infrastructure, limited availability of trained infusion nurses, reimbursement gaps, and regulatory requirements remain challenges. Access is also more developed in major urban centers than in many rural areas. Expansion of organized home healthcare providers and increasing patient awareness are expected to strengthen adoption as India’s healthcare system increasingly emphasizes convenient, patient-centered treatment models.

Saudi Arabia Healthcare Transformation and Digitalization Support Adoption

Saudi Arabia’s Home Infusion Therapy Market is benefiting from healthcare transformation, chronic disease prevalence, and increasing interest in home-based medical services. According to the International Diabetes Federation, approximately 7.3 million adults aged 20–79 in Saudi Arabia were living with diabetes in 2024, illustrating the country’s substantial long-term disease-management requirements. Patients with cancer, diabetes, immune disorders, chronic infections, and other complex conditions can require prolonged medication or supportive infusion therapy. Saudi Arabia’s Vision 2030 healthcare transformation program is promoting digital health, integrated care, preventive healthcare, and greater use of technology in healthcare delivery. Telemedicine and remote monitoring can help healthcare professionals supervise selected home treatments while reducing unnecessary facility visits. Advanced infusion equipment and organized home healthcare services are also improving treatment capabilities. However, shortages of specialized healthcare personnel, regulatory requirements, limited patient awareness, and medication-delivery logistics can constrain market expansion. In November 2023, Bupa Arabia expanded its home healthcare support services, including additional treatment options involving infusion therapy and chronic disease management. Continued investment in healthcare infrastructure and digital transformation is expected to support the development of home infusion services in Saudi Arabia.

Home Infusion Therapy Market Segments

Product

• Infusion Pump
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

Application

• Anti-Infective
• Hydration Therapy
• Chemotherapy
• Enternal Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

Country

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Pfizer Inc.
• Smith & Nephew plc
• Terumo Corporation
• Johnson & Johnson Services, Inc.
• Becton, Dickinson and Company
• Baxter International Inc.
• ICU Medical
• Eli Lilly and Company

Report Details: